References
Cushman M, Nagarathnam D, Burg DL, Geahlen RL (1991) Synthesis and protein-tyrosine kinase inhibitory activities of flavonoid analogue. J Med Chem 34:798–806
Havsteen B (1983) Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol 32:1141–1148
Nakadate T, Yamamoto S, Aizu E, Kato R (1984) Effects of flavonoids and antixidants on 12-O-tetradecanoylphorbol-13-acetate caused epidermal ornithine decarboxilase induction and tumour promotion in relation to lipoxigenase inhibition by these compounds. Jpn J Cancer Res 75:214
Vlietink AJ, Vanden Berghe DA, Haemers A (1988) In: Cody V, Middleton E Jr, Harbone JB, Beretz A (eds) Plant flavonoids in biology and medicine, vol II. Biochemical, cellular, and medicinal properties. Alan R. Liss, New York, pp 283–299
Minisalco A, Lundahl J, Regardh CG, Edgar B, Erisksson UG (1992) Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice. J Pharmacol Exp Ther 261:1195–1199
Bailey DG, Spence JD, Munoz C, Arnold JMO (1991) Interaction of citrus juices with felodopine and nifedipine. Lancet 337:268
Gandhi RK, Khanduja KL (1993) Impact of quercetin consumption on phase I and phase II drug-metabolizing enzymes in mice. J Clin Biochem Nutr 14:107–112
Scambia G, Ranelletti FO, Panici PB, De Vincenzo R, Bonanno G, Ferrandina G, Piantelli M, Bussa S, Rumi C, Cianfriglia M, Mancuso S (1994) Quercetin potentiates the effect of Adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target. Cancer Chemother Pharmacol 34:459–464
Gugler R, Leschik M, Dengler HJ (1975) Disposition of quercetin in man after single oral intravenous doses. Eur J Clin Pharmacol 9: 229–234
Buzzelli G, Moscarella S, Giusti A, Duchini A, Marena C, Lampertico M (1993) A pilot study on the liver protective effect of silybin-phosphatidylcholine complex (IdB1016) in chronic active hepatitis. J Clin Pharmacol 31:456–460
Elangovan V, Sekar N, Govindasamy S (1994) Chemopreventive potential of dietary bioflavonoids against 20-methylcholanthrene-induced tumorigenesis. Cancer Lett 87:107–113
Verma AK, Johnson JA, Gould MN, Tanner MA (1988) Inhibition of 7,12-dimehtylbenz(a)anthracene- andN-nitrosomethylurea-induced rat mammary cancer by dietary flavonol quercetin. Cancer Res 48:5754–5758
Hofmann J, Fiebig HH, Winterhalter BR, Berger DP, Grunicke H (1990) Enhancement of the antiproliferative activity ofcis-diaminedichloroplatinum(II) by quercetin. Int J Cancer 45:536–539
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Scambia, G., Ranelletti, F.O., Benedetti-Panici, P. et al. Reply to the letter to the editors. Cancer Chemother. Pharmacol. 36, 449–450 (1995). https://doi.org/10.1007/BF00686196
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00686196